AI Engines For more Details: Perplexity Kagi Labs You
Antidepressant Action: Desipramine hydrochloride is primarily used for the treatment of depression. It works by increasing the levels of certain neurotransmitters, specifically norepinephrine and serotonin, in the brain. By enhancing the activity of these neurotransmitters, desipramine helps improve mood, reduce feelings of sadness, and alleviate other symptoms of depression.
Tricyclic Antidepressant (TCA): Desipramine belongs to the class of tricyclic antidepressants, which were among the first medications developed for the treatment of depression. TCAs exert their therapeutic effects by blocking the reuptake of neurotransmitters such as norepinephrine and serotonin, thereby prolonging their activity in the brain and enhancing neurotransmission.
Off-Label Uses: In addition to depression, desipramine hydrochloride may be used off-label for the treatment of other psychiatric conditions such as anxiety disorders, panic disorder, obsessive-compulsive disorder (OCD), and attention-deficit/hyperactivity disorder (ADHD). It may also be used to manage certain chronic pain syndromes or neuropathic pain conditions.
Dosage and Administration: Desipramine hydrochloride is typically administered orally in the form of tablets or capsules, usually once or multiple times daily, as directed by a healthcare provider. The dosage may vary depending on the individual's age, weight, medical history, and response to treatment. It's important to follow the prescribed dosage and administration instructions carefully to achieve optimal therapeutic outcomes.
Onset of Action: Desipramine hydrochloride may take several weeks to achieve its maximum therapeutic effect in depression. Improvement in mood and reduction of depressive symptoms may not be noticeable until after several weeks of treatment. It's important for individuals taking desipramine to continue taking the medication as prescribed, even if they do not notice immediate improvement.
Side Effects: Common side effects of desipramine hydrochloride may include dry mouth, blurred vision, constipation, urinary retention, dizziness, drowsiness, weight gain, increased heart rate, and sexual dysfunction. These side effects are typically mild and transient but may become more pronounced at higher doses or with prolonged use. Desipramine may also cause anticholinergic side effects such as dry mouth, blurred vision, constipation, and urinary retention due to its anticholinergic properties.
Cardiovascular Effects: Desipramine hydrochloride may have cardiovascular effects, including orthostatic hypotension (a sudden drop in blood pressure upon standing), tachycardia (rapid heart rate), and arrhythmias (irregular heart rhythms). These effects may be more pronounced in individuals with pre-existing cardiovascular conditions or in those taking other medications that affect heart function.
Serotonin Syndrome: Like other antidepressants, desipramine hydrochloride may increase the risk of serotonin syndrome, a potentially life-threatening condition characterized by excessive serotonin levels in the brain. Serotonin syndrome may occur when desipramine is used in combination with other serotonergic medications, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), or monoamine oxidase inhibitors (MAOIs).
Withdrawal Symptoms: Abrupt discontinuation of desipramine hydrochloride may lead to withdrawal symptoms such as nausea, headache, dizziness, irritability, anxiety, insomnia, and flu-like symptoms. It is important to gradually taper the dosage of desipramine under medical supervision to minimize the risk of withdrawal effects.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Paraprevotella clara | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Prevotella bivia | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Prevotella dentalis | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.4 | |
Acne | 0.2 | -0.2 | |
ADHD | 2.4 | 1 | 1.4 |
Age-Related Macular Degeneration and Glaucoma | 0.1 | 0.1 | 0 |
Allergic Rhinitis (Hay Fever) | 1 | 2.1 | -1.1 |
Allergies | 4.2 | 2.7 | 0.56 |
Allergy to milk products | 1.4 | 0.8 | 0.75 |
Alopecia (Hair Loss) | 0.7 | 0.1 | 6 |
Alzheimer's disease | 3.4 | 4.2 | -0.24 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.8 | 0.8 | 2.5 |
Ankylosing spondylitis | 3.3 | 0.6 | 4.5 |
Anorexia Nervosa | 0.6 | 1.8 | -2 |
Antiphospholipid syndrome (APS) | 0.8 | 0.1 | 7 |
Asthma | 3.4 | 2.1 | 0.62 |
Atherosclerosis | 1.4 | 1.1 | 0.27 |
Atrial fibrillation | 2.4 | 2 | 0.2 |
Autism | 5.9 | 7.2 | -0.22 |
Autoimmune Disease | 0.4 | 0.3 | 0.33 |
Barrett esophagus cancer | 0.2 | 0 | 0 |
benign prostatic hyperplasia | 0.1 | 0.2 | -1 |
Biofilm | 0.6 | 0.6 | |
Bipolar Disorder | 1.1 | 1 | 0.1 |
Brain Trauma | 0.5 | 0.5 | 0 |
Breast Cancer | 0.2 | 0.2 | |
Cancer (General) | 0.5 | 1.6 | -2.2 |
Carcinoma | 1.8 | 1.1 | 0.64 |
Celiac Disease | 1.7 | 2.8 | -0.65 |
Cerebral Palsy | 1.2 | 0.4 | 2 |
Chronic Fatigue Syndrome | 2.8 | 4.5 | -0.61 |
Chronic Kidney Disease | 2.3 | 2.5 | -0.09 |
Chronic Lyme | 0.4 | 0.2 | 1 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 1 | -0.11 |
Chronic Urticaria (Hives) | 0.6 | 1.6 | -1.67 |
Coagulation / Micro clot triggering bacteria | 0.5 | 0.3 | 0.67 |
Cognitive Function | 0.7 | 0.5 | 0.4 |
Colorectal Cancer | 2.9 | 1.4 | 1.07 |
Constipation | 0.9 | 0.2 | 3.5 |
Coronary artery disease | 1.1 | 2.2 | -1 |
COVID-19 | 6.2 | 8.8 | -0.42 |
Crohn's Disease | 4 | 4.5 | -0.13 |
Cushing's Syndrome (hypercortisolism) | 0.4 | -0.4 | |
cystic fibrosis | 0.3 | 0.8 | -1.67 |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 1.2 | 0.2 | 5 |
Denture Wearers Oral Shifts | 0.6 | 0.6 | |
Depression | 6.5 | 6.7 | -0.03 |
Dermatomyositis | 0 | 0.2 | 0 |
Eczema | 0.5 | 0.7 | -0.4 |
Endometriosis | 1.6 | 1.4 | 0.14 |
Eosinophilic Esophagitis | 0.3 | -0.3 | |
Epilepsy | 2 | 1.8 | 0.11 |
erectile dysfunction | 0.3 | 0.2 | 0.5 |
Fibromyalgia | 1.2 | 1.8 | -0.5 |
Functional constipation / chronic idiopathic constipation | 3.4 | 2.6 | 0.31 |
gallstone disease (gsd) | 1.1 | 0.7 | 0.57 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.7 | 1.4 | -1 |
Generalized anxiety disorder | 1.9 | 1.9 | 0 |
giant cell arteritis | 0 | 0 | |
Glioblastoma | 0 | 0 | |
Gout | 1.1 | 0.8 | 0.38 |
Graves' disease | 0.9 | 1.3 | -0.44 |
Gulf War Syndrome | 0.5 | 1.8 | -2.6 |
Halitosis | 0.5 | 0 | 0 |
Hashimoto's thyroiditis | 1.8 | 1.6 | 0.13 |
Heart Failure | 2 | 1.8 | 0.11 |
hemorrhagic stroke | 0.1 | 0.1 | |
Hidradenitis Suppurativa | 0.7 | 0.2 | 2.5 |
High Histamine/low DAO | 0.3 | 0.3 | 0 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.6 | -0.2 |
hyperglycemia | 1 | 1.9 | -0.9 |
Hyperlipidemia (High Blood Fats) | 0.9 | 0.1 | 8 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 2.7 | 4 | -0.48 |
Hypothyroidism | 0.6 | 1.1 | -0.83 |
Hypoxia | 1.1 | 1.1 | |
IgA nephropathy (IgAN) | 0.8 | 3.3 | -3.12 |
Inflammatory Bowel Disease | 4.7 | 8 | -0.7 |
Insomnia | 1.1 | 2.6 | -1.36 |
Intelligence | 0.9 | 0.8 | 0.13 |
Intracranial aneurysms | 0.7 | 0.4 | 0.75 |
Irritable Bowel Syndrome | 4.1 | 3.6 | 0.14 |
ischemic stroke | 1.9 | 0.8 | 1.37 |
Liver Cirrhosis | 4.1 | 2.6 | 0.58 |
Long COVID | 5.3 | 5.7 | -0.08 |
Low bone mineral density | 1 | -1 | |
Lung Cancer | 0.6 | 1.1 | -0.83 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.1 | 0.5 | -4 |
ME/CFS with IBS | 0.2 | 2 | -9 |
ME/CFS without IBS | 1.3 | 1.1 | 0.18 |
membranous nephropathy | 0 | 0 | |
Menopause | 1.7 | 0.5 | 2.4 |
Metabolic Syndrome | 3.8 | 4.6 | -0.21 |
Mood Disorders | 7.5 | 6.3 | 0.19 |
multiple chemical sensitivity [MCS] | 0.8 | 0.3 | 1.67 |
Multiple Sclerosis | 4.2 | 4.1 | 0.02 |
Multiple system atrophy (MSA) | 1.3 | 0.4 | 2.25 |
myasthenia gravis | 0.1 | 0 | 0 |
neuropathic pain | 0.5 | 2.1 | -3.2 |
Neuropathy (all types) | 1.2 | 0.8 | 0.5 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.8 | 4.7 | -0.68 |
NonCeliac Gluten Sensitivity | 1.8 | 0.4 | 3.5 |
Obesity | 6.7 | 4.9 | 0.37 |
obsessive-compulsive disorder | 3.2 | 3 | 0.07 |
Osteoarthritis | 0.9 | 1.2 | -0.33 |
Osteoporosis | 1 | 1.2 | -0.2 |
pancreatic cancer | 0.3 | 0 | 0 |
Parkinson's Disease | 5.4 | 4.7 | 0.15 |
Polycystic ovary syndrome | 2.6 | 1.5 | 0.73 |
Postural orthostatic tachycardia syndrome | 0 | 0.5 | 0 |
Premenstrual dysphoric disorder | 0.5 | 0.1 | 4 |
primary biliary cholangitis | 0.3 | 0.2 | 0.5 |
Primary sclerosing cholangitis | 1.4 | 1.8 | -0.29 |
Psoriasis | 2 | 2.9 | -0.45 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.6 | 2.3 | 1 |
Rosacea | 0.4 | 0.1 | 3 |
Schizophrenia | 4.8 | 2.2 | 1.18 |
scoliosis | 0.6 | 0.7 | -0.17 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.3 | 1.5 | 0.53 |
Sleep Apnea | 0.7 | 1.1 | -0.57 |
Slow gastric motility / Gastroparesis | 0.6 | 0.2 | 2 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1 | 0.7 | 0.43 |
Stress / posttraumatic stress disorder | 1.2 | 2.2 | -0.83 |
Systemic Lupus Erythematosus | 2.1 | 1.3 | 0.62 |
Tic Disorder | 0.5 | 1.4 | -1.8 |
Tourette syndrome | 0.5 | 0.2 | 1.5 |
Type 1 Diabetes | 2.6 | 2.5 | 0.04 |
Type 2 Diabetes | 4.7 | 3.9 | 0.21 |
Ulcerative colitis | 2.4 | 5 | -1.08 |
Unhealthy Ageing | 2.3 | 1.9 | 0.21 |
Vitiligo | 1.2 | 1.4 | -0.17 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]